IVI and Panama


IVI Member State

On October 28, 1996, The Permanent Representative of Panama to the United Nations, H.E. George E. Illueca, signed the IVI Establishment Agreement.


Chikungunya Vaccine Development

As part of the Global Chikungunya vaccine Clinical Development (GCCDP) consortium, IVI will conduct Phase 2/3 clinical trials of Baharat Biotech’s BBV87 chikungunya vaccine candidate in Colombia, Panama, and Thailand.

Press release on GCCDP consortium